Fig. 4From: Enhancing prognostic accuracy in head and neck squamous cell carcinoma chemotherapy via a lipid metabolism-related clustered polygenic modelThe LMRS model had independent prognostic value when compared with single genes and other clinical characteristics. A–H, Overall survival curve of the low- and high-expression subgroups for LMRS factors: ACSBG2, APOB, IKBKB, MAPK9, MOGAT2, PLA2G10, PIK3R3, and SREBF1. I–K, Decision curve analysis (DCA) for drug response prediction for HNSCCs with and without the LMRS model at 1, 3, and 5 yearsBack to article page